How to Write a 510(k) in Accordance with Part 807 Requirements

Failure to write an acceptable 510(k), including the formatting and presenting of all the documented evidence to support claims of substantial equivalence can result in endless delays. Delays driven by the agency’s failure to accept or round-after-round of clarification questions can take a process that is expected to last just 90-days to several months past the initial 90-day target. The endless delays end up costing device establishment valuable revenue dollars lost, due to these delays.

Speed to market is everything for medical device establishments. Considering all of the costs associated with the design and development of medical devices, it is imperative that device establishments quickly and successfully navigate the often treacherous regulatory waters associated with the FDA’s 510(k) process. Establishing substantial equivalence to a predicate device is premised on the successful scripting of a 510(k), supported by empirical evidence.

This presentation by industry expert, Dr. Christopher Devine is a must-attend for all industry professionals, involved in the 510(k) process will benefit from this training as the 510(k) is a salient requirement for placing Class II device onto the US market through claims of substantial equivalence.

Areas Covered in the Session :

  • Understanding the different types of 510(k)s (traditional, special, and abbreviated)
  • Understanding the meaning of substantial equivalence
  • Deliverables required for a traditional 510(k) – brief review of each section
  • 510(k) Formatting
  • FDA required forms (3601, 3881, & 3654)
  • Pre-review & Screening Checklists
  • Fees
  • Preparation of paper and e-copy
  • Failure to Accept
  • FDA review deficiencies, how to correctly respond to a deficiency

Who Will Benefit:

  • Regulatory Affairs Departments
  • Research & Development Departments
  • Quality Assurance Departments
  • Quality Control Departments
  • Quality System Management
  • Consultants
  • Senior management

Dr. Christopher J. Devine

Dr. Christopher Joseph Devine is the president and founder of Devine Guidance International, Inc., (DGII) a consulting firm providing regulatory and quality compliance support for the medical device industry. Prior to launching DGII, Dr. D spent 14-years with Boston Scientific Corporation working in a variety of quality and regulatory management roles. Additionally, Dr. Devine is the author of Devine Guidance, a weekly blog focusing on quality and regulatory compliance issues facing the medical device industry; and published by the Medical Device Summit, an e-magazine.

Furthermore, Dr. Devine has 35-years of combined experience in the fields of quality assurance and regulatory affairs; and is a senior member of the American Society of Quality (ASQ), a member of Regulatory Affairs Professionals Society (RAPS), a member of the Society of Manufacturing Engineers (SME), and a member of the Project Management Institute (PMI).

Dr. Devine received his doctorate from Northcentral University, with his doctoral dissertation entitled, “Exploring the Effectiveness of Defensive-Receiving Inspection for Medical Device Manufacturers: A Mixed-Method Study. Finally, Dr. Devine is the author of five books on quality and regulatory compliance.

membership
  Go PRIME   🛈 $ 240 SELECT
  Personal Plan 🛈 $ 3000 SELECT
  Business Plan 🛈 $ 9000 SELECT


  • Login Information with Password to join the session, 24 hours prior to the webinar
  • Presentation Handout in .pdf format
  • Presentation from the Speaker
  • Feedback form
  • Certificate of Attendance
  • Recording access Information with Password to view the webinar, will be sent 24 hours after the completion of the Live webinar.
  • Presentation Handout in .pdf format
  • Certificate of Attendance